Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of CME Group Inc. (NASDAQ:CME)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on February 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on January 9th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Banco Santander (NYSE:SAN) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Leonardo (OTCMKTS:FINMF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 1/30/2026.
• Purchased $1,001 – $15,000 in shares of Transdigm Group (NYSE:TDG) on 1/30/2026.
• Purchased $1,001 – $15,000 in shares of Cloudflare (NYSE:NET) on 1/30/2026.
• Purchased $1,001 – $15,000 in shares of AutoZone (NYSE:AZO) on 1/30/2026.

CME Group Stock Performance

CME stock opened at $308.09 on Friday. CME Group Inc. has a 1-year low of $246.91 and a 1-year high of $309.35. The business has a 50-day moving average price of $283.19 and a 200 day moving average price of $274.78. The company has a market capitalization of $111.10 billion, a P/E ratio of 27.61, a PEG ratio of 3.60 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the firm posted $2.52 EPS. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. As a group, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, March 10th. This is an increase from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio is presently 44.80%.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. This trade represents a 27.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. This represents a 1.19% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 26,048 shares of company stock worth $7,054,920. Corporate insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in CME. Empowered Funds LLC boosted its holdings in CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after acquiring an additional 1,037 shares in the last quarter. Johnson Investment Counsel Inc. purchased a new position in shares of CME Group in the 2nd quarter valued at approximately $289,000. MGO One Seven LLC boosted its stake in CME Group by 19.9% in the 2nd quarter. MGO One Seven LLC now owns 6,553 shares of the financial services provider’s stock worth $1,806,000 after purchasing an additional 1,089 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in CME Group by 5.9% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 11,196 shares of the financial services provider’s stock worth $3,086,000 after purchasing an additional 627 shares during the last quarter. Finally, RFG Advisory LLC acquired a new position in CME Group during the 2nd quarter valued at approximately $716,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CME has been the topic of several research reports. Weiss Ratings reissued a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Piper Sandler increased their target price on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Raymond James Financial cut their price target on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. The Goldman Sachs Group upped their price objective on CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a research note on Monday, February 9th. Finally, Bank of America raised their price objective on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $299.53.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME’s formal announcement to offer 24/7 trading for crypto futures and options — a move that addresses the timing gap with always‑on spot crypto markets and could lift ADV and fee revenue; the company cited record crypto notional volume in 2025. CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Widespread coverage emphasizes the practical impacts — continuous trading can reduce “CME gaps,” boost institutional flow and expand crypto derivatives ADV, supporting the bullish thesis for trading‑fee growth. CME targets May launch for 24/7 crypto derivatives trading
• Positive Sentiment: Analyst/fin‑media bullishness — some outlets include CME among top picks, arguing the firm converts market volatility into trading revenue, which supports the stock’s rally. 2 Best Stocks to Buy Right Now for February
• Neutral Sentiment: Macro/market context — broader market moves (small‑cap rotation and sector flows) could be influencing intraday moves in financials/exchanges but are not specific to CME’s fundamentals. Small Caps Stage Quiet Comeback As AI Trade Shows Cracks
• Neutral Sentiment: Reported short‑interest data appears immaterial or inconsistent (no meaningful change reported); it isn’t currently signaling a large positioning risk.
• Negative Sentiment: Insider selling — director Martin J. Gepsman sold 300 shares; small in size but noteworthy as a disclosed insider sale. Insider Sale: Martin J. Gepsman
• Negative Sentiment: Critical takeaways — at least one outlet warns of risks to the CME thesis (valuation and competitive/operational risks), which could temper enthusiasm if amplified by further negative coverage. 2 Reasons CME is Risky and 1 Stock to Buy Instead

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.